Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kwag, Rina | - |
dc.contributor.author | Lee, Jieon | - |
dc.contributor.author | Kim, Doyoung | - |
dc.contributor.author | Lee, Haeun | - |
dc.contributor.author | Yeom, Miyoung | - |
dc.contributor.author | Woo, Jiwan | - |
dc.contributor.author | Cho, Yakdol | - |
dc.contributor.author | Kim, Hak Joong | - |
dc.contributor.author | Kim, Jeongjin | - |
dc.contributor.author | Keum, Gyochang | - |
dc.contributor.author | Jeon, Byungsun | - |
dc.contributor.author | Choo, Hyunah | - |
dc.date.accessioned | 2024-01-19T14:01:48Z | - |
dc.date.available | 2024-01-19T14:01:48Z | - |
dc.date.created | 2021-10-21 | - |
dc.date.issued | 2021-09 | - |
dc.identifier.issn | 0022-2623 | - |
dc.identifier.uri | https://pubs.kist.re.kr/handle/201004/116555 | - |
dc.description.abstract | 5-HT7R belongs to a family of G protein-coupled receptors and is associated with a variety of physiological processes in the central nervous system via the activation of the neurotransmitter serotonin (5-HT). To develop selective and biased 5-HT7R ligands, we designed and synthesized a series of pyrazolyl-diazepanes 2 and pyrazolyl-piperazines 3, which were evaluated for binding affinities to 5-HTR subtypes and functional selectivity for G protein and beta-arrestin signaling pathways of 5-HT7R. Among them, 1-(3-(3-chlorophenyl)-1H-pyrazol-4-yl)-1,4-diazepane 2c showed the best binding affinity for 5-HT7R and selectivity over other 5-HTR subtypes. It was also revealed as a G protein-biased antagonist. The self-grooming behavior test was performed with 2c in vivo with Shank3(-/-) transgenic (TG) mice, wherein 2c significantly reduced self-grooming duration time to the level of wild-type mice. The results suggest that 5-HT7R could be a potential therapeutic target for treating autism spectrum disorder stereotypy. | - |
dc.language | English | - |
dc.publisher | AMER CHEMICAL SOC | - |
dc.title | Discovery of G Protein-Biased Antagonists against 5-HT7R | - |
dc.type | Article | - |
dc.identifier.doi | 10.1021/acs.jmedchem.1c01093 | - |
dc.description.journalClass | 1 | - |
dc.identifier.bibliographicCitation | JOURNAL OF MEDICINAL CHEMISTRY, v.64, no.18, pp.13766 - 13779 | - |
dc.citation.title | JOURNAL OF MEDICINAL CHEMISTRY | - |
dc.citation.volume | 64 | - |
dc.citation.number | 18 | - |
dc.citation.startPage | 13766 | - |
dc.citation.endPage | 13779 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.identifier.wosid | 000701513400038 | - |
dc.identifier.scopusid | 2-s2.0-85115981902 | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Medicinal | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.type.docType | Article | - |
dc.subject.keywordPlus | COUPLED RECEPTORS | - |
dc.subject.keywordPlus | SEROTONIN RECEPTORS | - |
dc.subject.keywordPlus | LIGANDS | - |
dc.subject.keywordPlus | DESIGN | - |
dc.subject.keywordPlus | MODEL | - |
dc.subject.keywordPlus | MOUSE | - |
dc.subject.keywordPlus | DRUG | - |
dc.subject.keywordPlus | SCHIZOPHRENIA | - |
dc.subject.keywordPlus | PHARMACOPHORE | - |
dc.subject.keywordPlus | OPTIMIZATION | - |
dc.subject.keywordAuthor | autism spectrum disorder | - |
dc.subject.keywordAuthor | GPCR | - |
dc.subject.keywordAuthor | 5-HT7R | - |
dc.subject.keywordAuthor | neurodevelopmental disorders | - |
dc.subject.keywordAuthor | biased antagonist | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.